bromocriptine has been researched along with amphetamine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (36.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kellams, JJ; Lemberger, L; Rowe, H; Small, JG | 1 |
| Johnson, AM; Loew, DM; Vigouret, JM | 1 |
| Calne, DB; Claveria, LE; Reid, JL | 1 |
| Décio, RC; Frussa-Filho, R; Monteiro, Mdo C; Soares, CG | 1 |
| Ross, RG; Ward, NG | 1 |
| Davis, A; Jenner, P; Marsden, CD | 1 |
| Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S | 1 |
| Lyman, CP; O'Brien, RC | 1 |
| Jenner, P; Marsden, CD; Reavill, C | 1 |
| Willner, P | 1 |
| Király, I; Van Ree, JM | 1 |
| Bevan, P | 1 |
| Jaehkel, M; Oehler, J; Schumacher, HE | 1 |
| Atrens, DM; Hunt, GE; Jackson, DM | 1 |
| Conceição, IM; Frussa-Filho, R | 1 |
| Chen, JC; Hsieh, MM; Huang, LI; Su, HJ | 1 |
| Munn, E; Neklesa, T; Ranaldi, R; Wise, RA | 1 |
| Auerbach, PP; Cadenhead, K; Eastvold, A; Geyer, MA; Karban, B; Ploum, Y; Stephany, N; Swerdlow, NR | 1 |
| Auerbach, PP; Sharp, R; Stephany, N; Swerdlow, NR; Talledo, J; Wasserman, LC | 1 |
| Richer, E; Tell, L | 1 |
| Bakheit, AM | 1 |
| de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P | 1 |
| Robbins, TW; Winstanley, CA; Zeeb, FD | 1 |
5 review(s) available for bromocriptine and amphetamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dopamine and depression: a review of recent evidence. I. Empirical studies.
Topics: Amphetamine; Antipsychotic Agents; Brain; Bromocriptine; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Double-Blind Method; Homovanillic Acid; Humans; Norepinephrine; Parkinson Disease; Piribedil; Receptors, Dopamine; Research | 1983 |
[Indications, efficacy and tolerance of drug therapy in view of improving recovery of consciousness following a traumatic brain injury].
Topics: Amphetamine; Brain Injuries; Bromocriptine; Central Nervous System Stimulants; Coma; Consciousness; Databases, Factual; Dopamine Agonists; Humans; Methylphenidate; Neurotransmitter Agents; Persistent Vegetative State; Prognosis; Treatment Outcome | 2003 |
Drug treatment of poststroke aphasia.
Topics: Amphetamine; Aphasia; Bromocriptine; Humans; Stroke | 2004 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem | 2007 |
20 other study(ies) available for bromocriptine and amphetamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Topics: Acetonitriles; Amphetamine; Animals; Behavior; Bromocriptine; Dopamine Antagonists; Drug Interactions; Ergolines; Fluphenazine; Humans; Levodopa; Male; Rats; Stereotyped Behavior | 1977 |
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra | 1976 |
Hypothermic action of bromocriptine.
Topics: Amphetamine; Animals; Apomorphine; Body Temperature Regulation; Brain; Bromocriptine; Cold Temperature; Colon; Dopamine Antagonists; Dose-Response Relationship, Drug; Environment, Controlled; Ergolines; Hypothermia; Male; Pimozide; Rats | 1975 |
Effects of haloperidol, bromocriptine and amphetamine on the development of Ehrlich ascites carcinoma in mice.
Topics: Amphetamine; Analysis of Variance; Animals; Bromocriptine; Carcinoma, Ehrlich Tumor; Disease Models, Animal; Haloperidol; Male; Mice; Neoplasm Transplantation; Random Allocation | 1992 |
Bromocriptine abuse.
Topics: Adult; Amphetamine; Arousal; Bromocriptine; Cocaine; Dose-Response Relationship, Drug; Humans; Male; Substance-Related Disorders | 1992 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior | 1988 |
A pharmacological study of hibernation in rodents.
Topics: Adrenalectomy; Amphetamine; Animals; Bromocriptine; Cricetinae; Droxidopa; Epinephrine; Hibernation; Isoproterenol; Levodopa; Mesocricetus; Norepinephrine; Phenylephrine; Sciuridae | 1988 |
Metabolite involvement in bromocriptine-induced circling behaviour in rodents.
Topics: Amphetamine; Animals; Apomorphine; Biotransformation; Bromocriptine; Desipramine; Female; Hydroxydopamines; Male; Medial Forebrain Bundle; Methyltyrosines; Mice; Motor Activity; Nomifensine; Paralysis; Proadifen; Rats; Receptors, Dopamine; Receptors, Neurotransmitter; Reserpine; Sleep; Zoxazolamine | 1980 |
Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; beta-Endorphin; Bromocriptine; Dopamine; Endorphins; Ergolines; Fluphenazine; gamma-Endorphin; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Sulpiride | 1984 |
Effect of muscarinic ligands on the electrical activity recorded from the hippocampus: a quantitative approach.
Topics: Amphetamine; Animals; Arecoline; Bromocriptine; Electrophysiology; Hippocampus; Injections, Intravenous; Male; N-Methylscopolamine; Neurons, Afferent; Oxotremorine; Parasympathetic Nervous System; Parasympathomimetics; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Stereotaxic Techniques | 1984 |
Individual motor activity--relationships to dopaminergic responses.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred A; Motor Activity; Phenotype; Stereotyped Behavior | 1994 |
Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Brain; Bromocriptine; Conditioning, Operant; Dopamine D2 Receptor Antagonists; Drug Interactions; Electric Stimulation; Male; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Reinforcement Schedule; Reward; Self Stimulation; Spiperone | 1994 |
Effects of microgram doses of haloperidol on open-field behavior in mice.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity | 1996 |
Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization.
Topics: Adenylyl Cyclases; Amphetamine; Analysis of Variance; Animals; Bromocriptine; Colforsin; Corpus Striatum; Cyclic AMP; Drug Administration Schedule; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Injections, Intraperitoneal; Male; Motor Activity; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors | 1999 |
Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
Topics: Amphetamine; Animals; Bromocriptine; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; Morphine; Motor Activity; Narcotics; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 2000 |
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
Topics: Adolescent; Adult; Amantadine; Amphetamine; Analysis of Variance; Blood Pressure; Bromocriptine; Dopamine Agonists; Double-Blind Method; Heart Rate; Humans; Male; Pergolide; Psychomotor Performance; Reflex, Startle; Time Factors | 2002 |
Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm.
Topics: Adult; Amphetamine; Analysis of Variance; Association Learning; Bromocriptine; Case-Control Studies; Conditioning, Classical; Dopamine Agonists; Dopamine Uptake Inhibitors; Humans; Inhibition, Psychological; Male; Photic Stimulation; Reaction Time | 2003 |
Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bromocriptine; Choice Behavior; Conditioning, Operant; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Models, Animal; Piperazines; Pyridines; Quinpirole; Rats; Rats, Long-Evans; Reward; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Task Performance and Analysis | 2009 |